If and how nutrient preference impacts cell identity has been a longstanding mystery for scientists—until a team of Salk ...
Fate Therapeutics has announced encouraging initial data from the FT819 phase 1 autoimmunity study for people with ...
Institute of Immunobiology-led research has made a significant breakthrough in understanding how the body combats lung cancer ...
All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion ...
Researchers from the A*STAR Institute of Molecular and Cell Biology (IMCB) have identified Nr1h2, a critical transcription ...
Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, ...
Fate Therapeutics (FATE) presented new clinical and translational data from the company’s FT819 Phase 1 Autoimmunity study for ...
On the outskirts of Sednaya prison, known as Syria’s “human slaughterhouse,” a hidden underground complex was uncovered, ...
About Fate Therapeutics’ iPSC Product Platform Human induced pluripotent stem cells (iPSCs) possess the unique dual properties of unlimited self-renewal and differentiation potential into all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback